Experienced in Cholangiocarcinoma (Bile Duct Cancer)

Janessa J. Laskin

BC Cancer
Vancouver, BC, CA 
Experienced in Cholangiocarcinoma (Bile Duct Cancer)
BC Cancer
Vancouver, BC, CA 
OverviewLocationsClinical Research

Overview

Janessa Laskin practices in Vancouver, Canada. Ms. Laskin is rated as an Experienced expert by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). Her top areas of expertise are Pancreatic Ductal Adenocarcinoma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Tissue Biopsy, and Splenectomy.

Her clinical research consists of co-authoring 149 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Cholangiocarcinoma (Bile Duct Cancer).

Gender
Female

Locations

BC Cancer
Vancouver, BC, Canada
Other Locations
BC, Canada
BC Cancer
Surrey, BC V3V1Z2, Canada
Victoria, BC, Canada
Abbotsford, BC V2S0C2, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 1/2 Study of Oral Selpercatinib (LOXO-292) in Patients With Advanced Solid Tumors, Including RET Fusion-Positive Solid Tumors, Medullary Thyroid Cancer, and Other Tumors With RET Activation (LIBRETTO-001)
A Phase 1/2 Study of Oral Selpercatinib (LOXO-292) in Patients With Advanced Solid Tumors, Including RET Fusion-Positive Solid Tumors, Medullary Thyroid Cancer, and Other Tumors With RET Activation (LIBRETTO-001)
Enrollment Status: Active_not_recruiting
Publish Date: June 04, 2025
Intervention Type: Drug
Study Drug: Selpercatinib
Study Phase: Phase 1/Phase 2
Achieving Value in Cancer Diagnostics: Blood Versus Tissue Molecular Profiling - a Prospective Canadian Study
Achieving Value in Cancer Diagnostics: Blood Versus Tissue Molecular Profiling - a Prospective Canadian Study
Enrollment Status: Completed
Publish Date: May 15, 2023
Intervention Type: Diagnostic test
View 1 Less Clinical Trial

149 Total Publications

Cross-platform methylation-based site of origin classification for squamous cell carcinomas.
Cross-platform methylation-based site of origin classification for squamous cell carcinomas.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: February 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Laskin's expertise for a condition
ConditionClose
    View All 28 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile